MIFH
CLLS

Migdal Insurance & Financial Holdings’s Cellectis CLLS Stock Holding History

Migdal Insurance & Financial Holdings’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-23,224
Closed -$469K – 604
2021
Q1 		$469K Buy
23,224
+14,412
+164% +$356K ﹤0.01% 328
2020
Q4 		$238K Buy
+8,812
New +$198K ﹤0.01% 297

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

Migdal Insurance & Financial Holdings's CLLS Position: Q2 2021 in Review

Migdal Insurance & Financial Holdings sold out of Cellectis (CLLS) in Q2 2021, closing a stake of 23,224 shares — an estimated $469K sold.

Migdal Insurance & Financial Holdings first reported a position in CLLS in Q4 2020 and held it in 2 quarters. The position peaked at $469K in Q1 2021. 78 funds tracked by Wall St. Rank hold CLLS as of Q2 2021.

  • Migdal Insurance & Financial Holdings reported no remaining Cellectis position as of Q2 2021 after selling out during the quarter.
  • Migdal Insurance & Financial Holdings sold 23,224 Cellectis shares in Q2 2021, an estimated $469K.
  • Migdal Insurance & Financial Holdings first reported a position in Cellectis in Q4 2020 and held it in 2 quarters.
  • Migdal Insurance & Financial Holdings's Cellectis position peaked at $469K in Q1 2021.
  • 78 funds tracked by Wall St. Rank held Cellectis as of Q2 2021.

Based on Migdal Insurance & Financial Holdings's 13F filing for Q2 2021, filed 4 Aug 2021.